Valrubicin
C34H36F3NO13
723.64
(2S-cis)-2-[1,2,3,4,6,11-Hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl) amino]-α-l-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl pentanoate;
(8S,10S)-8-Glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-l-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 82-valerate [56124-62-0]
(2S-cis)-2-[1,2,3,4,6,11-Hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl) amino]-α-l-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl pentanoate;
(8S,10S)-8-Glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-l-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 82-valerate [56124-62-0]
DEFINITION
Valrubicin contains NLT 98.0% and NMT 102.0% of C34H36F3NO13, calculated on the anhydrous and solvent-free basis.